Cynthia Lynn Anderson insider trades

Open-market stock purchases and sales by Cynthia Lynn Anderson, CHIEF FINANCIAL OFFICER at Vistagen Therapeutics, Inc, from SEC Form 4 filings since Aug 21, 2023.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • VTGN Vistagen Therapeutics, Inc: other filings, last Jun 30, 2025

Get free alerts when Cynthia Lynn Anderson files a new trade →